Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/38792
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3488]
Metadata
Show full item record
DIRECTLY OBSERVED THERAPY AND RISK OF UNFAVOURABLE TUBERCULOSIS TREATMENT OUTCOMES AMONG AN INTERNATIONAL COHORT OF PEOPLE LIVING WITH HIV IN LOW- AND MIDDLE-INCOME COUNTRIES
Body mass index
Directly observed therapy
Human immunodeficiency virus infection
Tuberculosis
Author
Affilliation
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA./ Vanderbilt Tuberculosis Center, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
College of Public Health, The Ohio State University, Columbus, OH, USA.
Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
Bach Mai Hospital, Hanoi, Vietnam.
TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Centre Intégré de Recherches Biocliniques d'Abidjan CIRBA, Abidjan, Côte d'Ivoire.
Centre INSERM U1219, Bordeaux Population Health, University of Bordeaux, Bordeaux, France.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA./ Vanderbilt Tuberculosis Center, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
College of Public Health, The Ohio State University, Columbus, OH, USA.
Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
Bach Mai Hospital, Hanoi, Vietnam.
TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Centre Intégré de Recherches Biocliniques d'Abidjan CIRBA, Abidjan, Côte d'Ivoire.
Centre INSERM U1219, Bordeaux Population Health, University of Bordeaux, Bordeaux, France.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA./ Vanderbilt Tuberculosis Center, Nashville, TN, USA.
Abstract
Identification of persons living with human immunodeficiency virus (HIV)-associated tuberculosis (TB) at increased risk for unfavourable TB outcomes would inform efforts to improve such outcomes. We sought to identify factors associated with a decreased risk of unfavourable TB treatment outcomes among people living with HIV-infection (PLHIV) in low- and middle-income countries (LMIC), with a specific focus on directly observed therapy (DOT) compared with self-administered therapy (SAT) during the continuation phase of anti-TB therapy.
Keywords
Antiretroviral therapyBody mass index
Directly observed therapy
Human immunodeficiency virus infection
Tuberculosis
Share